FAUXSEE INNOVATIONS LLC

MAGNOLIA, AR · Founded 2011 · Medtech · Private

Wearable glasses that convert speech to haptic (touch) sensations via embedded haptic technology and speech recognition, enabling deaf users to perceive speech through tactile feedback on the glasses

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
MAGNOLIA, AR
Founded
2011
Latest Form D
$47K, Nov 2013
Total capital
$823K
Federal grants
$776K
4 awards · 2015–2018
Rank in peer group#360 of 445
Private capital raised
$47K
1 Form D · last Nov 2013
156 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

201320142015201620172018FEDERAL ↑EQUITY ↓Cumulative $823K$100K$226K$225K$225K1st Form D$47K
201320142015201620172018FEDERAL ↑EQUITY ↓Cumulative $823K$100K$226K$225K$225K1st Form D$47K

Latest events

  • Federal grantHealth and Human S · Phase I · RoboHear device:advanced haptic technology that allows deaf to understand speech$225K
  • Federal grantHealth and Human S · Phase I · RoboHear™ device: advanced haptic technology that allows deaf to understand speech$225K
  • Federal grantHealth and Human S · Phase I · Roboglasses® electronic travel aid with hands free obstacle avoidance for blind and vision impaired users$226K
  • Federal grantAgriculture · Robofindtm - Safe & Efficient Rural Travel For The Blind$100K
  • Private capital raisedForm D · SEC · 1st filing$47K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 445 peers

Line = median

Medtech · Device

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Brandon FosheeExecutive Officer, DirectorNamed in SEC Form D filings
  • Timothy ZiglerExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • PHAST CORPSimilar federal contract value in Medtech · null in contracts
  • SCION NEUROSTIM, LLCSimilar federal contract value in Medtech · null in contracts
  • CONTRALINE, INC.Similar federal contract value in Medtech · null in contracts
  • CELL IDX, INC.Similar federal contract value in Medtech · null in contracts
  • PROTEAS BIOANALYTICS INC.Similar federal contract value in Medtech · null in contracts
  • GATEWAY BIOTECHNOLOGY, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .